Abramson Cancer Center - University of Pennsylvania

Site:	Abramson Cancer Center - University of Pennsylvania	Go to their website
Address:	38th and Walnut Streets
City:	Philadelphia
State:	PA
Zip:	19104
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075
1	Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas	Recruiting	Active	INBRX-109 + Temozolomide	NCT03715933
1	Phase I, Combining Oral Topotecan With Oral Pazopanib	Ongoing, but not recruiting	Closed	Pazopanib (Votrient) + Topetecan (Hycamtin)	NCT00732420